• Users Online: 4052
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Comparison of bevacizumab, ranibizumab and aflibercept in retinopathy of prematurity treatment
Elçin Süren,Dilek Özkaya,Ersan Çetinkaya,Mustafa Kalayci,Kenan Yigit,Mehmet Fatih Kücük,Muhammet Kazim Erol
International Ophthalmology.2022;42(6)1905
[DOI]
2Update on the Use of Anti-VEGF Drugs in the Treatment of Retinopathy of Prematurity
Christopher W. Seery,Saul Betesh,Suqin Guo,Marco A. Zarbin,Neelakshi Bhagat,Rudolph S. Wagner
Journal of Pediatric Ophthalmology & Strabismus.2020;57(6)351
[DOI]
3Comparison of two different doses of intravitreal aflibercept in the treatment of retinopathy of prematurity
Dilbade Yildiz Ekinci,Asli Deger Vural
Journal of American Association for Pediatric Ophthalmology and Strabismus.2021;25(2)93.e1
[DOI]
4Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
Nada O. Taher,Abdullah A. Ghaddaf,Sarah A. Al-Ghamdi,Jumanah J. Homsi,Bandar J. Al-Harbi,Lugean K. Alomari,Hashem S. Almarzouki
Frontiers in Medicine.2022;9(2)93.e1
[DOI]
5Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
Hamid Riazi-esfahani,Alireza Mahmoudi,Mehdi Sanatkar,Afsar Dastjani Farahani,Fatemeh Bazvand
International Journal of Retina and Vitreous.2021;7(1)93.e1
[DOI]
6Erratum: Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
Hamid Riazi-esfahani,Alireza Mahmoudi,Mehdi Sanatkar,Afsar Dastjani Farahani,Fatemeh Bazvand
Indian Journal of Ophthalmology.2019;67(9)1513
[DOI]
7New trends in intravitreal anti-VEGF therapy for ROP
Alfredo Beccasio,Costanza Mignini,Anna Caricato,Barbara Iaccheri,Giuseppe Di Cara,Alberto Verrotti,Carlo Cagini
European Journal of Ophthalmology.2022;32(3)1340
[DOI]
8Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity
Ana Bety Enríquez,Robert L. Avery,Caroline R. Baumal
Asia-Pacific Journal of Ophthalmology.2020;9(4)358
[DOI]
9Aflibercept for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
Po-Yu (Jay) Chen,Elizabeth J. Rossin,Demetrios G. Vavvas
Ophthalmic Surgery, Lasers and Imaging Retina.2021;52(12)673
[DOI]
10Efficacy of Aflibercept Treatment and Its Effect on the Retinal Perfusion in the Oxygen-Induced Retinopathy Mouse Model of Retinopathy of Prematurity
Sarina M. Amin,Andres Gonzalez,Jade Guevara,Charlotte Bolch,Lorick Andersen,W. Clay Smith,Swati Agarwal-Sinha
Ophthalmic Research.2021;64(1)91
[DOI]
11Low-dose ranibizumab administration in retinopathy of prematurity
Levent Tök,Lütfi Seyrek,Özlem Yalçin Tök
International Ophthalmology.2022;42(5)1545
[DOI]
12The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity—a current review
Shing Chuen Chow,Pun Yuet Lam,Wai Ching Lam,Nicholas Siu Kay Fung
Eye.2022;36(8)1532
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal